Statistics for Systemic CD4 immunity and PD-L1/PD-1 blockade immunotherapy
Total visits
| views | |
|---|---|
| Systemic CD4 immunity and PD-L1/PD-1 blockade immunotherapy | 62 |
Total visits per month
| views | |
|---|---|
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 1 |
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 0 |
File Visits
| views | |
|---|---|
| Escors_SystemicCD4.pdf | 57 |
Top country views
| views | |
|---|---|
| United States | 40 |
| China | 3 |
| Spain | 2 |
| Austria | 1 |
| Switzerland | 1 |
| France | 1 |
| Iran | 1 |
| Malaysia | 1 |
| Netherlands | 1 |
| Taiwan | 1 |
Top city views
| views | |
|---|---|
| Oakland | 14 |
| Atlanta | 4 |
| Mountain View | 3 |
| Pamplona | 2 |
| Providence | 2 |
| Redmond | 2 |
| Sacramento | 2 |
| Amsterdam | 1 |
| Ann Arbor | 1 |
| Asheville | 1 |
| Basel | 1 |
| Durham | 1 |
| Edmond | 1 |
| Fairfield | 1 |
| Fremont | 1 |
| Guangzhou | 1 |
| Nanjing | 1 |
| Shanghai | 1 |
| Taipei | 1 |
| Vienna | 1 |